Furthermore, IL-6 favors tumorigenesis by creating an immunosuppressive tumor microenvironment, as the induction of JAK/STAT3 signaling has an inhibitory effect on, for example, dendritic cells, effector T cells, and natural killer cells [52,86]. The gene discussed is STAT3; the disease is neoplasm.